Confirmation of family cancer history reported in a population-based survey

Journal of the National Cancer Institute

Volumn 103, Issue 10, 2011, Pages 788-797

  Mai, Phuong L ^a   Garceau, Anne O ^a   Graubard, Barry I ^a   Dunn, Marsha ^b   McNeel, Timothy S ^c   Gonsalves, Lou ^d   Gail, Mitchell H ^a   Greene, Mark H ^a   Willis, Gordon B ^a   Wideroff, Louise ^e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WESTAT   (United States)

^c INFORMATION MANAGEMENT SERVICES INC   (United States)

^d Connecticut Tumor Registry ^*  (United States)

^e NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; BREAST CANCER; CANCER REGISTRY; COLORECTAL CANCER; DEATH CERTIFICATE; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; HEALTH SURVEY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSTATE CANCER; RELATIVE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ADULT; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; CONNECTICUT; DEATH CERTIFICATES; FAMILY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MEDICAL HISTORY TAKING; MEDICAL RECORDS; MEDICARE; MIDDLE AGED; NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS; QUESTIONNAIRES; REGISTRIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 79957442482     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djr114     Document Type: Article

References (38)

1. Yoon PW, Scheuner MT, Jorgensen C, Khoury MJ. Developing Family Healthware, a family history screening tool to prevent common chronic diseases. Prev Chronic Dis. 2009;6(1):A33.
2. Yoon PW, Scheuner MT, Peterson-Oehlke KL, Gwinn M, Faucett A, Khoury MJ. Can family history be used as a tool for public health and preventive medicine? Genet Med. 2002;4(4):304-310. (Pubitemid 44698565)
3. Freedman AN, Graubard BI, Rao SR, McCaskill-Stevens W, Ballard-Barbash R, Gail MH. Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst. 2003;95(7):526-532. (Pubitemid 36511623)
4. US Preventive Services Task Force. Guide to Clinical Preventive Services. http://www.uspreventiveservicestaskforce.org/adultrec.htm#cancer. Accessed December 22, 2009.
5. Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Cancer screening in the United States, 2010: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2010;60(2):99-119.
6. Loescher LJ, Crist JD, Siaki LA. Perceived intrafamily melanoma risk communication. Cancer Nurs. 2009;32(3):203-210.
7. Matthews AK, Cummings S, Thompson S, Wohl V, List M, Olopade OI. Genetic testing of African Americans for susceptibility to inherited can-cers: Use of focus groups to determine factors contributing to participa-tion. J Psychosocial Oncol. 2000;18(2):1-19. (Pubitemid 30666496)
8. Kenen R, Arden-Jones A, Eeles R. We are talking, but are they listening? Communication patterns in families with a history of breast/ovarian can-cer (HBOC). Psychooncology. 2004;13(5):335-345. (Pubitemid 38714195)
9. Koehly LM, Peters JA, Kenen R, et al. Characteristics of health informa-tion gatherers, disseminators, and blockers within families at risk of hered-itary cancer: Implications for family health communication interventions. Am J Public Health. 2009;99(12):2203-2209.
10. Qureshi N, Wilson B, Santaguida P, et al. Collection and Use of Cancer Family History in Primary Care. Rockville, MD: Agency for Healthcare Research and Quality; 2007. Evidence Report/Technology Assessment No. 159 (prepared by the McMaster University Evidence-based Practice Center, under Contract No. 290-02-0020). AHRQ Publication No. 08-E001.
11. US Department of Health and Human Services. Surgeon General's Family Health History Initiative. http://www.hhs.gov/familyhistory/. Accessed December 22, 2009.
12. Murff HJ, Byrne D, Syngal S. Cancer risk assessment: Quality and impact of the family history interview. Am J Prev Med. 2004;27(3):239-245. (Pubitemid 39278324)
13. Sifri RD, Wender R, Paynter N. Cancer risk assessment from family his-tory: Gaps in primary care practice. J Fam Pract. 2002;51(10):856. http://www.jfponline.com/Pages.asp?AID=1965&issue=October%202002&;UID= 51:000. Accessed June 12, 2010.
14. Mitchell RJ, Brewster D, Campbell H, et al. Accuracy of reporting of family history of colorectal cancer. Gut. 2004;53(2):291-295. (Pubitemid 38125521)
15. Sijmons RH, Boonstra AE, Reefhuis J, et al. Accuracy of family history of cancer: Clinical genetic implications. Eur J Hum Genet. 2000;8(3):181-186. (Pubitemid 30189861)
16. Acheson LS, Wiesner GL, Zyzanski SJ, Goodwin MA, Stange KC. Family history-taking in community family practice: Implications for genetic screening. Genet Med. 2000;2(3):180-185. (Pubitemid 32010820)
17. Berg AO, Baird MA, Botkin JR, et al. National Institutes of Health State-of-the-Science Conference Statement: Family History and Improving Health. Ann Intern Med. 2009;151(12):872-877.
18. Garceau A, Wideroff L, McNeel T, Dunn M, Graubard BI. Population estimates of extended family structure and size. Community Genet. 2008;11(6):331-342.
19. Levy PS, Lemeshow S. Sampling of Populations: Methods and Applications. 3rd ed. New York, NY: John Wiley and Sons, Inc; 1999.
20. Tucker C, Casady R, Lepkoski J. Sample allocation for stratified tele-phone sample designs. Proceedings of the Survey Research Methods Section, ASA. 1992:291-296.
21. Rizzo L, Graubard B, DiGaetano R, Wideroff L. Establishing rates for the family history of Cancer Validation Study. Proceedings of the Survey Research Methods Section, ASA. 2000:683-687.
22. Rust KF, Rao JN. Variance estimation for complex surveys using replica-tion techniques. Stat Methods Med Res. 1996;5(3):283-310. (Pubitemid 126559356)
23. Qureshi N, Wilson B, Santaguida P, et al. NIH State-of-the-Science Conference: Family History and Improving Health. Rockville, MD: AHRQ, 2009. AHRQ Publication No. 09-E016. Evidence Report/Technology Assessment No. 186. (Prepared by the McMaster University Evidence-based Practice Center, under Contract No. 290-2007-10060-I).
24. Murff HJ, Spigel DR, Syngal S. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer his-tory. JAMA. 2004;292(12):1480-1489. (Pubitemid 39258342)
25. Freedman AN, Slattery ML, Ballard-Barbash R, et al. Colorectal cancer risk prediction tool for white men and women without known suscepti-bility. J Clin Oncol. 2009;27(5):686-693.
26. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabil-ities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879-1886. (Pubitemid 20026073)
27. Robson ME, Storm CD, Weitzel J, Wollins DS, Offit K. American Society of Clinical Oncology policy statement update: Genetic and ge-nomic testing for cancer susceptibility. J Clin Oncol. 2010;28(5):893-901.
28. Ziogas A, Anton-Culver H. Validation of family history data in cancer family registries. Am J Prev Med. 2003;24(2):190-198. (Pubitemid 36144098)
29. Douglas FS, O'Dair LC, Robinson M, Evans DGR, Lynch SA. The accu-racy of diagnoses as reported in families with cancer: A retrospective study. J Med Genet. 1999;36(4):309-312. (Pubitemid 29161064)
30. Hay J, Shuk E, Brady MS, Berwick M, Ostroff J, Halpern A. Family com-munication after melanoma diagnosis. Arch Dermatol. 2008;144(4):553-554.
31. Kerber RA, Slattery ML. Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidemiol. 1997;146(3):244-248. (Pubitemid 27329725)
32. Glanz K, Grove J, Le Marchand L, Gotay C. Underreporting of family history of colon cancer: Correlates and implications. Cancer Epidemiol Biomarkers Prev. 1999;8(7):635-639. (Pubitemid 29337325)
33. Ederer F, Geisser MS, Mongin SJ, Church TR, Mandel JS. Colorectal cancer deaths as determined by expert committee and from death certificate: A comparison. The Minnesota Study. J Clin Epidemiol. 1999;52(5):447-452. (Pubitemid 29305350)
34. Doria-Rose VP, Marcus PM. Death certificates provide an adequate source of cause of death information when evaluating lung cancer mor-tality: An example from the Mayo Lung Project. Lung Cancer. 2009;63(2):295-300.
35. Freedman DM, Sigurdson AJ, Doody MM, Love-Schnur S, Linet MS. Comparison between cancers identified by state cancer registry, self-report, and death certificate in a prospective cohort study of US radiologic technologists. Int J Epidemiol. 2006;35(2):495-497.
36. Barzilai DA, Koroukian SM, Neuhauser D, Cooper KD, Rimm AA, Cooper GS. The sensitivity of medicare data for identifying incident cases of invasive melanoma (United States). Cancer Causes Control. 2004;15(2):179-184. (Pubitemid 38445364)
37. Penberthy L, McClish D, Manning C, Retchin S, Smith T. The added value of claims for cancer surveillance: Results of varying case definitions. Med Care. 2005;43(7):705-712. (Pubitemid 40993766)
38. Cooper GS, Yuan Z, Stange KC, Dennis LK, Amini SB, Rimm AA. The sensitivity of Medicare claims data for case ascertainment of six common cancers. Med Care. 1999;37(5):436-444.